• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY, INC. ORBERA 365 INTRAGASTRIC BALLOON SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY, INC. ORBERA 365 INTRAGASTRIC BALLOON SYSTEM Back to Search Results
Model Number B-50012
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Patient Problem/Medical Problem (2688)
Event Date 06/18/2020
Event Type  malfunction  
Manufacturer Narrative
Medwatch submitted to the fda.A review of the device labeling notes the following: the current orbera® intragastric balloon system directions for use (dfu) addresses the known and anticipated potential events of "difficulty adding/removing saline" and "difficulty with fill tube" are as follows: warnings and precautions: proper positioning of the placement catheter assembly and the orbera® system balloon within the stomach is necessary to allow proper inflation.Lodging of the balloon in the esophageal opening during inflation may cause injury and/or device rupture.The orbera® system balloon is composed of soft silicone elastomer and is easily damaged by instruments or sharp objects.The balloon must be handled only with gloved hands and with the instruments recommended in this document.Note: if the balloon becomes separated from the sheath prior to placement, do not attempt to use the balloon or reinsert the balloon into the sheath.Note: during the filling process the fill tube must remain slack.If the fill tube is under tension during the intubation process, the fill tube may dislodge from the balloon, preventing further balloon deployment.Warning: rapid fill rates will generate high pressure which can damage the orbera® system valve or cause premature detachment.
 
Event Description
"the balloon is introduced without incidents.When filling a leak of the saline solutions & methylene blue is noticed, and a rupture in the valve is confirmed.".
 
Manufacturer Narrative
Supplement #1 medwatch submitted to the fda on 02/dec/2020.After multiple attempts to gather more information from the reporter, no additional information has been received.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORBERA 365 INTRAGASTRIC BALLOON SYSTEM
Type of Device
INTRAGASTRIC BALLOON
Manufacturer (Section D)
APOLLO ENDOSURGERY, INC.
1120 s. capital of texas hwy
bldg 1, ste. 300
austin, tx
MDR Report Key10295508
MDR Text Key199537084
Report Number3006722112-2020-00064
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
PMA/PMN Number
P140008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 12/02/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/10/2021
Device Model NumberB-50012
Device Catalogue NumberB-50012
Device Lot NumberAF03407
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/26/2020
Initial Date FDA Received07/20/2020
Supplement Dates Manufacturer Received06/26/2020
Supplement Dates FDA Received12/02/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age24 YR
Patient Weight85
-
-